comparemela.com

Latest Breaking News On - Otcmkts nvtrq - Page 1 : comparemela.com

Nuvectra (OTCMKTS:NVTRQ) Stock Crosses Below 50 Day Moving Average of $0 02

Nuvectra Corp (OTCMKTS:NVTRQ – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.02 and traded as low as $0.02. Nuvectra shares last traded at $0.02, with a volume of 382,600 shares trading hands. Nuvectra Stock Down 25.0 % The […]

Nuvectra (OTCMKTS:NVTRQ) Stock Price Crosses Below 50 Day Moving Average of $0 02

Nuvectra Corp (OTCMKTS:NVTRQ – Get Free Report) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.02 and traded as low as $0.02. Nuvectra shares last traded at $0.02, with a volume of 382,600 shares changing hands. Nuvectra Stock Performance The stock’s 50-day simple […]

Nuvectra (OTCMKTS:NVTRQ) Share Price Crosses Below 50-Day Moving Average of $0 02

Shares of Nuvectra Corp (OTCMKTS:NVTRQ – Get Free Report) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.02 and traded as low as $0.02. Nuvectra shares last traded at $0.02, with a volume of 382,600 shares. Nuvectra Stock Performance The firm has a fifty […]

Nuvectra (OTCMKTS:NVTRQ) Stock Passes Below Fifty Day Moving Average of $0 02

Nuvectra Corp (OTCMKTS:NVTRQ – Get Rating) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.02 and traded as low as $0.02. Nuvectra shares last traded at $0.02, with a volume of 382,600 shares trading hands. Nuvectra Stock Down 25.0 % The company’s […]

Financial Review: Nuvectra (OTCMKTS:NVTRQ) vs Sight Sciences (NASDAQ:SGHT)

Nuvectra (OTCMKTS:NVTRQ – Get Rating) and Sight Sciences (NASDAQ:SGHT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Analyst Recommendations This is a summary of current ratings and […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.